LeMaitre George W, Chairman and CEO of LeMaitre Vascular (LMAT), has demonstrated a clear selling bias in his recent insider transactions, with no open-market purchases recorded in the available data. Across 49 reported trades, his total sell activity amounts to $31.75 million, dwarfing his $1.35 million in buy transactions. The most significant disposals occurred on February 26, 2026, when he sold $16.01 million worth of LMAT shares, followed by a $6.03 million sale on March 2, 2026. These large-scale disposals were accompanied by smaller transactions, including multiple stock awards (coded "A") and option exercises (coded "M") in December 2025, where he acquired shares at prices ranging from $192,229 to $375,823 before subsequent sales.
The trading pattern shows LeMaitre consistently reducing his position in LMAT, with all recent transactions being sales rather than acquisitions. While he has received periodic stock awards—most recently on March 26, 2026—these have not been accompanied by offsetting purchases. The absence of buy transactions since at least December 2025 suggests a sustained disposition trend rather than routine portfolio rebalancing. His sales, particularly the two multi-million-dollar transactions in early 2026, represent the most significant liquidity events in the reported period. All activity remains confined to LeMaitre Vascular, with no trades in other securities disclosed.
AI-assisted summary